TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL June 11, 2014
TCL Archive Also NCI Cancels von Eschenbach’s Farewell Party, Returns Gift Contributions Amid Ethics Questions. May 19, 2006
TCL Archive In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman June 29, 1979
TCL Archive FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza December 26, 2014